HADHB, a fatty acid beta-oxidation enzyme, is a potential prognostic predictor in malignant lymphoma

Pathology. 2022 Apr;54(3):286-293. doi: 10.1016/j.pathol.2021.06.119. Epub 2021 Sep 14.

Abstract

In haematological malignancies, such as malignant lymphoma, reprogramming of fatty acid metabolism favours tumour cell survival and drug resistance. Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha (HADHA), an enzyme involved in fatty acid beta-oxidation (FAO), is overexpressed in high-grade lymphoma and is a predictor of poor prognosis in diffuse large B-cell lymphoma (DLBCL). HADHB forms a heterodimer with HADHA and functions as an FAO enzyme together with HADHA; however, the relevance of its expression in malignant lymphoma is unknown. In this study, we investigated the roles and antitumour effects of HADHB expression in malignant lymphoma. Immunohistochemical analysis showed that HADHB was frequently overexpressed in the high-grade lymphoma subtype. HADHB overexpression was observed in 68% (87/128) of DLBCL cases and was an independent predictor of poor prognosis (p=0.001). In vitro analysis demonstrated that HADHB knockdown suppressed cell proliferation in LCL-K and MD901 cells (p<0.05). Additionally, treatment with the FAO inhibitor, ranolazine, increased cell death in control cells compared with that in HADHB knockdown LCL-K and MD901 cells (p<0.01). Cell death was also suppressed by the ferroptosis inhibitor, ferrosatin-1, in LCL-K and MD901 cells (p<0.05). Collectively, these findings provide basic evidence for the development of new cell death-based therapies for refractory malignant lymphoma. We plan to perform prospective studies and preclinical studies using animal models to confirm these results.

Keywords: HADHB; Malignant lymphoma; fatty acid beta-oxidation; prognostic factor; therapeutic target.

MeSH terms

  • Animals
  • Fatty Acids / metabolism
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / diagnosis
  • Mitochondrial Trifunctional Protein, beta Subunit* / metabolism
  • Prognosis
  • Prospective Studies

Substances

  • Fatty Acids
  • HADHB protein, human
  • Mitochondrial Trifunctional Protein, beta Subunit